drugset
drugset / Trial / NCT00930293

Efficacy and Feasibility of a Personalized Treatment for Depression With Co-Occurring Anxiety

NCT00930293 ↗

Completed 50 enrolled University of Pittsburgh National Institute of Mental Health (NIMH) · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will examine the feasibility and efficacy of a personalized psychotherapy treatment for people with depression and co-occurring anxiety.

Timeline

Start
2009-07
Primary completion
2012-06
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Citalopram Small molecule 10 mg —
Subject Citalopram Small molecule 60 mg —

Indications

anxiety depressive disorder